No joke…2011 CDC Guidelines is now available…

The long awaited update to the 2002 CDC Guidelines for the Prevention of Intravascular Catheter -Related Infections was released today April 1 by the  Centers for Disease Control and Prevention (CDC) and the Healthcare Infection Control Practices Advisory Committee (HICPAC). The 2011 guidelines  outline steps to eliminate bloodstream infections in patients with intravenous catheters, which…

Survey Results: Standards of Practice

Here are the results of the survey from a  previous post “Take our survey: Standards of Practice”. Q1  Are you aware that there is a Standard of Practice for Infusion Nursing?   n=75 Yes:  82.5%                      No:  17.65% Q2  If you are an RN, LPN or APN performing, administering, delivering IV/infusion therapy, do you think the…

Closing out 2010..

The last day of the year and yes, 2010 went by so fast.  I consider myself lucky for it was a good year f0r me professionally and an equally good year for this blog as well. Through this blog, I have met so many wonderful individuals,  learned so much from them, and very grateful for…

FDA Alerts/Recall: Several infusion related products

In the past weeks, there have several FDA alerts and recall notices related to products used in infusion therapy. Here are some of the products. Class I Recall: CareFusion Corporation, Alaris PC Units (Model 8015) Reason for Recall: Under certain wireless network conditions, a communication error can occur, which freezes the PC Unit screen. This…

Vesicants: not just chemo agents!

There is no doubt that several chemotherapeutic agents have vesicant properties, and when inadvertently infused into the surrounding tissue from an infiltrated IV, these agents may have the potential to cause blisters, severe tissue injury or necrosis, known as extravasation. The damage to the tissue can occur from direct contact with the vesicant medication, from…

Overheard in an Infusion Center….

“ we’re just like a filling station, they (patients) come here, we fill them up and let them go”!! This was the response from several RN’s working in a hospital based outpatient infusion center I recently visited where chemotherapy and biologic agents are administered to patients with oncologic and non-oncologic disorders, including patient’s with immune…

FDA Safety Alert on Nimodipine: Not for IV use

Nimodipine is a medication intended to be given in a critical care setting to treat neurologic complications from subarachnoid hemorrhage and is only available as a capsule. The U.S. Food and Drug Administration (FDA) is alerting healthcare professionals that nimodipine capsules should be given ONLY by mouth or through a feeding tube (nasogastric tube). This…

FDA Requires Baxter to recall Colleague Infusion Pump

On July 13, 2010, the U.S. Food and Drug Administration required Baxter Healthcare Corp. to take specific steps to carry out the April 2010 recall of all Colleague Volumetric Infusion Pumps (CVIP) and to provide customers with a refund, a replacement pump, or lease termination. According to the FDA, it is requiring Baxter to provide…